Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Technology Development: Page 4
Fusion Genomics secures $1M U.S. to study respiratory infections panel
By
LabPulse.com staff writers
The Consortium Québécois sur la Découverte du Medicament (CQDM) is a Montreal-based biomedical research consortium that funds new technologies with potential value in facilitating drug discovery and development. The organization noted that since it was founded in 2008, it has raised more than $118 million Canadian ($90 million U.S.) through Canadian government programs and a wide range of pharmaceutical industry partners, including Merck, Pfizer, AstraZeneca, and Eli Lilly.
January 9, 2020
MilliporeSigma licenses CRISPR tech to Promega
By
LabPulse.com staff writers
Promega will use MilliporeSigma's CRISPR genome-editing technology to create research products and services, including those for drug development.
December 19, 2019
Bio-Rad launches QX One PCR system at AMP 2019
By
LabPulse.com staff writers
The product features automated workflow incorporating all steps involved in the company's ddPCR technology. Bio-Rad designed the single, integrated system for use in drug development and manufacturing quality control and said that it can analyze up to 480 samples per day.
November 10, 2019
NIH announces recipients of early-career 'genomic innovator' award
By
LabPulse.com staff writers
The program is set to award approximately $500,000 annually over a project period of five years, the NIH said. The NHGRI created the award program last year as a means of supporting early-career investigators in genome biology, genomic medicine, technology development, and societal implications of genomic advances.
August 27, 2019
Qiagen and DiaSorin heed call for better Lyme disease test
By
LabPulse.com staff writers
Development of the test for Lyme disease, which is also called borreliosis and is transmitted by blacklegged ticks, will build on an ongoing collaboration to combine Qiagen's QuantiFeron interferon gamma release technology and DiaSorin's Lyme disease testing arrays.
June 5, 2019
Previous Page
Page 4 of 4